Clinical studies on GLP-1 receptor agonists, including Saxenda, Wegovy, Ozempic, and Mounjaro , provide valuable insight into their long-term efficacy: Saxenda (Liraglutide) A 3-year study showed: 56% of participants reached and maintained target weight loss in year one With continuous use, many maintained weight loss over 3 years Success was highest when paired with lifestyle interventions (diet + exercise) Risk of weight regain increased if Saxenda was discontinued without behavioral support Wegovy (Semaglutide) STEP 4 trial (68 weeks) showed: Patients who continued Wegovy maintained a 14.8% weight loss Those who stopped the medication regained about two-thirds of the weight within 1 year Suggests Wegovy is effective long-term , but requires ongoing treatment or strong lifestyle adherence Ozempic (Semaglutide) (used off-label for weight loss) In studies where Ozempic was used weekly: Weight loss was sustained as long as treatment continued Discontinuation led to partial weight regain , though not as rapid as in untreated individuals Works well when paired with structured eating plans Mounjaro (Tirzepatide) Strongest Long-Term Outcome to Date SURMOUNT-1 trial: After 72 weeks , participants lost up to 22.5% of body weight Even after treatment ended, those who adopted lifestyle changes were able to keep the weight off Its dual action on both GLP-1 and GIP receptors improves: Insulin sensitivity Appetite regulation Metabolism regulation Early data suggests Mounjaro has the lowest likelihood of rebound weight gain , especially when combined with follow-up care Comparing Saxenda, Wegovy, Ozempic, and Mounjaro 1
![tirzepatide eye twitch Zepbound Problems: An Exhaustive and Informative Patient Guide [2025] 1,344 Eye Twitching Royalty-Free Images,](https://www.shutterstock.com/image-vector/droopy-eye-anxiety-fatigue-stress-260nw-2246138345.jpg)
Consent for publication The author reviewed and approved the final version and has agreed to be accountable for all aspects of the work, including any accuracy or integrity issues
As per good clinical practice, a daily dose of 3 mg was prescribed for 30 days at the first visit and increased to 7 mg per day starting from the second month
Visit LifeRx.md to start your journey toward lasting, sustainable weight losson your terms, without insurance hassles.
281 Inflammation in OA is closely related to the activation of macrophages